Abstract
To evaluate the safety and efficacy of prostate artery embolization (PAE) for the treatment of symptomatic benign prostatic hyperplasia (BPH) for prostate glands greater than 80 g, a cohort of patients limited in management options given the size of the prostate
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have